May 21, 2024
Market Now
Daewha Pharma receives US$20m order from NovoSci in UAE
[DISCLOSURE] Daewha Pharmaceutical (067080) reported on Oct. 12 that it has inked a US$20.12 million five-year contract with NovoSci in United Arab Emirates to supply pharmaceutical products under the condition its products are granted approval for sale in 11 countries including Saudi Arabia.
This amounts to 16.16 percent of its revenue last year.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
This amounts to 16.16 percent of its revenue last year.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
